Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With NIDDM: a Placebo-Controlled Dose-Response Study With Insulin Aspart (Novorapid).
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms NIDDM
- 10 Jun 2017 Biomarkers information updated
- 04 Nov 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 04 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.